Recently, Johnson & Johnson announced plans to acquire Abbott’s Ophthalmology Business (AMO) for $4.3 billion to refine and expand its presence in the field of ophthalmic medical services. Then, in the future, the development of ophthalmology medical services will be a glimpse of the development of Aier Ophthalmology, a well-known company in the field of ophthalmology.

Aier Ophthalmology's revenue growth in the first half of the year

On August 20th, Aier Ophthalmology announced its annual report for the first half of 2016. The data showed that the number of outpatients in the first half of the year reached 1,787,100, a year-on-year increase of 25.21%; the number of operations was 186,800, a year-on-year increase of 27.62%; 1.92 billion yuan, an increase of 32.02%; the net profit attributable to shareholders of the parent company was 273 million yuan, an increase of 34.98%.

The company's main business is ophthalmic medical services and optometry medical services, of which ophthalmic medical services mainly include refractive surgery, cataract surgery, anterior segment surgery, posterior segment surgery and other operations. At the same time, the income of the main business projects includes the registration of medical records, medical treatment income, medical income, surgical income, hospital income and so on.

Among them, the two major businesses that contribute the most profit from the company are refractive surgery and optometry services. Revenue in the first half of the year has maintained nearly 40% growth, refractive surgery realized income of 560 million yuan, an increase of 39.68%, optometry services income of 380 million yuan, an increase of 39.13% over the same period, making the company's operating income continued to maintain rapid growth.

Shanghai Aier Ophthalmology Specialist Clinic List

Interpretation of ophthalmology related terms, from Aier Ophthalmology semi-annual report

Disposable Nitrile Gloves

ZHANGJIAGANG DINSHENGLIN TRADING CO.,LTD , https://www.dslhouse.com